Multitargeted Tyrosine Kinase Inhibitor GSK1363089
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Protein Kinase Inhibitor ->
Tyrosine Kinase Inhibitor -> Multitargeted Tyrosine Kinase Inhibitor GSK1363089
Multitargeted Tyrosine Kinase Inhibitor GSK1363089 Definition
An orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers. VEGFR2 is found on endothelial and hematopoietic cells and mediates the development of the vasculature and hematopoietic cells through VEGF signaling.
Multitargeted Tyrosine Kinase Inhibitor GSK1363089 Synonyms
Multitargeted Tyrosine Kinase Inhibitor GSK1363089, GSK1363089, XL880
Terms in Multitargeted Tyrosine Kinase Inhibitor GSK1363089 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.